Lactylation Genes LDHA and LDHC Alleviate Osteoarthritis by Reducing Specific B‐Cell Expression: Mechanistic Exploration and Experimental Validation
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70935 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Jingkai Di und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: B-Lymphocytes, L-Lactate Dehydrogenase, Osteoarthritis, Knee, Lactate Dehydrogenase 5. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Central Guidance of Local Science and Technology Development Funds, Shanxi Provincial Scientific and Technological Achievement Transformation Guidance Special Program.
Abstract (Originalsprache)
This study aims to elucidate the correlation between the lactylation‐related genes and the progression of knee osteoarthritis (KOA). Integrating genome‐wide association study data and expression quantitative trait locus data, Mendelian randomisation (MR) and summary‐data‐based MR analyses assessed the correlation between lactylation‐related genes and KOA, validated candidates in chondrocytes by RNA‐seq, western blotting (WB) and quantitative reverse transcriptase PCR (qRT‐PCR). Moreover, CCK‐8, transwell migration and scratch assays were conducted to assess the proliferation/migration. Finally, mediation analysis was utilised to explore the downstream mechanisms. LDHA and LDHC expression was significantly downregulated in the KOA group, as confirmed by RNA‐seq, WB and qRT‐PCR analyses. Functional experiments also confirmed that the down‐regulation of LDHA or LDHC expression could produce a chondrocyte proliferation and migration inhibitory effect similar to that of the OA group, while restoring the expression of these two genes could significantly reverse this phenotype. Furthermore, mediation analysis revealed that CD38 on IgD + CD24− B lymphocytes mediated the protective effect of these genes against KOA, with CD25+ memory B cells also serving as mediators for LDHC's impact on KOA. LDHA and LDHC are identified as therapeutic targets for KOA, providing promising targets and ideas for the development of new treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Second Hospital of Shanxi Medical University, Taiyuan, China.
- Shanxi Key Laboratory of Bone and Soft Tissue Injury Repair, Taiyuan, China.
- The First Hospital of Shanxi Medical University, Taiyuan, China.
- The Fifth Hospital of Shanxi Medical University, Taiyuan, China.
- The Second Hospital of Shanxi Medical University, Taiyuan, China.
ORCID-Profile: Chuan Xiang
Förderung
- Central Guidance of Local Science and Technology Development Funds
- Shanxi Provincial Scientific and Technological Achievement Transformation Guidance Special Program
Zitieren
APA
Di, J., Guo, Z., Di, Y., Chen, T., Qin, Y., Xing, X., & Xiang, C. (2025). Lactylation Genes LDHA and LDHC Alleviate Osteoarthritis by Reducing Specific B‐Cell Expression: Mechanistic Exploration and Experimental Validation. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70935
Vancouver
Di J, Guo Z, Di Y, Chen T, Qin Y, Xing X, et al. Lactylation Genes LDHA and LDHC Alleviate Osteoarthritis by Reducing Specific B‐Cell Expression: Mechanistic Exploration and Experimental Validation. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70935
BibTeX
@article{Di2025,
author = {Di, Jingkai and Guo, Zijian and Di, Yijing and Chen, Tingting and Qin, Yingda and Xing, Xinglong and Xiang, Chuan},
title = {Lactylation Genes LDHA and LDHC Alleviate Osteoarthritis by Reducing Specific B‐Cell Expression: Mechanistic Exploration and Experimental Validation},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70935}
}
EUVIMED